Bio-Research.AI is an AI-native DaaS company founded in 2022 and specialized in the pharmaceutical and biotech industry. The company supports data-driven decision-making for business development, investment, and strategy teams at global pharma, biotech, and investment institutions. After four years of developing AI systems for collecting, extracting, structuring, and validating global source data, Bio-Research.AI launched its platform in 2025. Built on proprietary industry data, a domain-specific pharma/biotech ontology, analytics, and AI technologies, the company supports technology, company and pipeline discovery, competitive landscape analysis, licensing deal benchmarking, clinical and regulatory research, and investment monitoring. As of July 2026, Bio-Research.AI serves about 70 paying customers across 17 countries, with more than 70% of revenue generated overseas and a 90% retention rate, demonstrating early product-market fit and repeat usage in global markets.